Rare diseases
Investigational molecules
Locations
Klinikstrasse 33, 35392 Giessen, Germany
Justus-Liebig-Universitaet Giessen in Giessen, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Pulmonary arterial hypertension, Idiopathic pulmonary fibrosis, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.
The clinical trial activity at Justus-Liebig-Universitaet Giessen focuses on eye diseases, with studies centered on conditions that can seriously affect vision and daily life. The main research interests include geographic atrophy and macular edema due to central retinal vein occlusion, reflecting a strong commitment to improving care in retinal disease.
These trials bring together a large investigator team and a clear ophthalmology focus, supporting research that explores both novel therapy options and ways to optimize existing treatment strategies.
At the Klinik und Poliklinik für Augenheilkunde, current research is directed toward retinal conditions that can lead to progressive visual impairment. The studies are designed to examine whether new treatment strategies can better address geographic atrophy and improve management of macular edema due to central retinal vein occlusion.
The site’s research profile highlights a practical interest in both innovative treatment development and the refinement of established ophthalmic care for patients with chronic retinal disease.
Clinical trials currently enrolling participants at this site.
Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
GermanyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyStudy on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack
GermanyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
GermanyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
GermanyStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
GermanyA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
GermanyAdjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma
GermanyEfficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
GermanyPhase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)
GermanyPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
